Extending the capabilities of targeted molecular dynamics: Simulation of a large conformational transition in plasminogen activator inhibitor 1

Protein Science

Volumn 10, Issue 4, 2001, Pages 798-808

  Krüger, Peter ^a   Verheyden, Stefan ^a   Declerck, Paul J ^a   Engelborghs, Yves ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Conformational change; Molecular dynamics simulation; Pathway calculation; Plasminogen activator inhibitor 1; Serpin; Targeted molecular dynamics

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINASE; UROKINASE;

ARTICLE; CALCULATION; CONFORMATIONAL TRANSITION; MOLECULAR DYNAMICS; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN STRUCTURE; SIMULATION; THREE DIMENSIONAL IMAGING; X RAY ANALYSIS;

COMPUTER SIMULATION; CRYSTALLOGRAPHY, X-RAY; MODELS, MOLECULAR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; SERPINS;

EID: 0035085863     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.40401     Document Type: Article

References (41)

1. A model of the reactive form of plasminogen activator inhibitor-1
2. Mechanisms contributing to the conformational and functional flexibility of plasminogen activator inhibitor-1
3. Molecular dynamics with coupling to an external bath
4. The missing term in effective pair potentials
5. Molecular evolution of plasminogen activator inhibitor-1 functional stability
6. Mobile reactive centre of serpins and the control of thrombosis
7. Biological implications of a 3 Å structure of dimeric antithrombin
8. 1-antichymotrypsin in chronic bronchitis and emphysema
9. Real space refinement of the structure of hen-white lysozyme
10. Calculation of pathways for the conformational transition between GTP and GDP bound states of the Ha-ras-p21 protein
11. The T → R structural transition of insulin; pathways identified by targeted energy minimization
12. The structure of a serpin-protease complex revealed by intramolecular distance measurements using donor-donor energy migration and mapping of interaction sites
13. Identification of positively charged residues contributing to the stability of plasminogen activator inhibitor 1
14. Model-free methods of analyzing domain motions in proteins from simulation: A comparison of normal mode analysis and molecular dynamics simulation of lysozyme
15. Systematic analysis of domain motions in proteins from conformational change: New results on citrate synthase and T4 lysozyme
16. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants
17. Structure of a serpinprotease complex shows inhibition by deformation
18. Simulation of a complex protein structural change: The T ↔ R transition in the insulin hexamer
19. Pathophysiology of fibrinolysis
20. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures
21. SIMLYS - Version 2.0 simulations
22. SIMLYS - A software package for trajectory analysis of molecular dynamics simulations
23. Molecular dynamics of native protein. II. Analysis and nature of motion
24. 1-antitrypsin
25. Molecular switch in signal transduction: Reaction paths of the conformational changes in ras p21
26. Structural basis of latency in plasminogen activator inhibitor-1
27. Plasminogen activator inhibitor-1: Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation
28. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: Low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor
29. Simulations of the T ↔ R conformational transition in aspartate transcarbamylase
30. On the size of the active site in proteases
31. Targeted molecular dynamics simulation of conformational change - Application to the T-R transition in insulin
32. Targeted molecular dynamics: A new approach for searching pathways of conformational transitions
33. The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion
34. Algorithms for macromolecular dynamics and constraint dynamics
35. Studies of recombinant plasminogen activator inhibitor-1 in rabbits. Pharmacokinetics and evidence for reactivation of latent plasminogen activator inhibitor-1 in vivo
36. Effect of stabilizing versus destabilizing interactions on plasminogen activator inhibitor-1
37. Conformational changes in serpins. I. The native and cleaved conformations of α1-antitrypsin
38. Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins
39. Predictive value of fibrinolytic factors in coronary heart disease
40. Modeling pathways of α-chymotrypsin and deactivation